Search Results - "MAYEUR, Didier"

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy by Zelek, Laurent, Debourdeau, Philippe, Bourgeois, Hugues, Wagner, Jean Philippe, Brocard, Fabien, Lefeuvre‐Plesse, Claudia, Chauffert, Bruno, Leheurteur, Marianne, Bachet, Jean‐Baptiste, Simon, Hélène, Mayeur, Didier, Scotté, Florian

“…Background Neurokinin (NK) 1 receptor antagonists (RAs), administered in combination with a 5‐hydroxytryptamine‐3 (5‐HT3) RA and dexamethasone (DEX), have…”
Get full text

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers by Ballot, Elise, Galland, Loïck, Mananet, Hugo, Boidot, Romain, Arnould, Laurent, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia, Hennequin, Audrey, Bergeron, Anthony, Derangère, Valentin, Ghiringhelli, François, Truntzer, Caroline, Ladoire, Sylvain

“…Abstract Purpose The vast majority of research studies that have described the links between DNA damage repair or homologous recombination deficiency (HRD)…”
Get full text

Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry by Ladoire, Sylvain, Mamguem Kamga, Ariane, Galland, Loick, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia Mihaelia, Hennequin, Audrey, Jankowski, Clementine, Albuisson, Juliette, Nambot, Sophie, Coutant, Charles, Arnould, Laurent, Reda, Manon, Truntzer, Caroline, Dabakuyo, Sandrine

“…The results of the OlympiA study led to the approval of a PARP inhibitor (olaparib) as adjuvant treatment for early breast cancer (eBC) at high risk of relapse…”
Get full text

Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results by Réda, Manon, Fouquier, Anaïs, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia, Hennequin, Audrey, Coudert, Bruno, Bertaut, Aurélie, Ladoire, Sylvain

“…Taxanes are major drugs for metastatic breast cancer (MBC) treatment, and are generally well tolerated, making them attractive for therapeutic reintroduction…”
Get full text

Trastuzumab-emtansine induced pleural and pericardial effusions by Lombardi, Jeffrey, Lory, Pauline, Martin, Nils, Mayeur, Didier, Combret, Sandrine, Grandvuillemin, Aurélie, Boulay, Charlène, Schmitt, Antonin

“…Introduction Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate which combine trastuzumab (T), a monoclonal antibody targeting the human epidermal…”
Get full text

Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study by MARIANI, Pascale, BLUMBERG, Joelle, LANDAU, Alain, LEBRUN-JEZEKOVA, Daniela, BOTTON, Estelle, BEATRIX, Olivier, MAYEUR, Didier, HERVE, Robert, MAISONOBE, Pascal, CHAUVENET, Laure

“…To investigate the somatostatin analog lanreotide as symptomatic treatment for inoperable bowel obstruction due to peritoneal carcinomatosis. In all, 80…”
Get full text

PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy by Le Gouill-Jaijarat, Christele, Péréon, Yann, Leroy, Maxime, Lépine, Olivier, Loloum, Aymeric, Peluchon, Claire, Volteau, Christelle, Martineau, Anne-Sophie, Korner, Simon, Perrault, Caroline, Benmaziane, Asmahane, Girot, Paul, Petorin, Caroline, Perret, Clément, Ligeza-Poisson, Catherine, Mayeur, Didier, Flet, Laurent, Chiffoleau, Anne, Poinas, Alexandra, Bennouna, Jaafar

“…Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common adverse effects of antineoplastic agents, ranging in prevalence from 19% to over…”
Get full text

Population Pharmacokinetics of Palbociclib in a Real-World Situation by Royer, Bernard, Kaderbhaï, Courèche, Fumet, Jean-David, Hennequin, Audrey, Desmoulins, Isabelle, Ladoire, Sylvain, Ayati, Siavoshe, Mayeur, Didier, Ilie, Sivia, Schmitt, Antonin

“…Palbociclib is an oral cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with…”
Get full text

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients by Marouille, Alexandre, Petit, Emma, Kaderbhaï, Courèche, Desmoulins, Isabelle, Hennequin, Audrey, Mayeur, Didier, Fumet, Jean-David, Ladoire, Sylvain, Tharin, Zoé, Ayati, Siavoshe, Ilie, Silvia, Royer, Bernard, Schmitt, Antonin

“…Palbociclib is an oral CDK4/6 inhibitor indicated in HR+/HER2- advanced or metastatic breast cancer in combination with hormonotherapy. Its main toxicity is…”
Get full text

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing by Galland, Loïck, Ballot, Elise, Mananet, Hugo, Boidot, Romain, Lecuelle, Julie, Albuisson, Juliette, Arnould, Laurent, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia, Hennequin, Audrey, Bergeron, Anthony, Derangère, Valentin, Ghiringhelli, François, Truntzer, Caroline, Ladoire, Sylvain

“…Metastatic breast cancer (MBC) is frequently managed by platinum-based chemotherapy during the disease course. The real benefit of these treatments is…”
Get full text

The official French guidelines to protect patients with cancer against SARS-CoV-2 infection by You, Benoit, Ravaud, Alain, Canivet, Anne, Ganem, Gérard, Giraud, Philippe, Guimbaud, Rosine, Kaluzinski, Laure, Krakowski, Ivan, Mayeur, Didier, Grellety, Thomas, Lotz, Jean-Pierre

“…On request of the French Health Ministry, the French High Council for Public health (Haut Conseil de Santé Publique [HCSP]) entrusted a representative group of…”
Get full text

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative Group by TOURANI, Jean-Marc, PFISTER, Christian, MAYEUR, Didier, RIXE, Olivier, SUN, Xu-Shan, BERNARD, Olivier, ANDRE, Thierry, TOURNIGAND, Christophe, MURACCIOLE, Xavier, GUILHOT, Joelle, TUBIANA, Nicole, OULDKACI, Mahmoud, PREVOT, Gilles, LUCAS, Virginie, OUDARD, Stéphane, MALET, Maxime, COTTU, Paul, FERRERO, Jean-Marc

“…This outpatient multicenter trial tested the hypothesis that subcutaneous administration of an interleukin-2 (IL-2)/interferon alfa (IFN alpha) combination…”
Get full text

Supportive oncology care, unconventional practices and integrative oncology: The need for clarification by Träger, Stéphanie, Mayeur, Didier, Poulain, Philippe, Perraudin, Florence, Krakowski, Ivan

“…This article begins by tracing the history of supportive oncology care, from its definition to its regulation and organization in France. It then recalls the…”
Get more information

Factors influencing the use of thromboprophylaxis in cancer outpatients: CAT AXIS, a case-vignette study on clinical practice by Scotte, Florian, Elalamy, Ismail, Mayeur, Didier, Meyer, Guy

“…Abstract only e18276 Background: Data on long-term venous thromboembolism (VTE) prophylaxis in cancer outpatients remain scarce. Our objective was to describe…”
Get full text

Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study by Mahé, Isabelle, Agnelli, Giancarlo, Ay, Cihan, Bamias, Aristotelis, Becattini, Cecilia, Carrier, Marc, Chapelle, Céline, Cohen, Alexander T, Girard, Philippe, Huisman, Menno V, Klok, Frederikus A, López-Núñez, Juan J, Maraveyas, Anthony, Mayeur, Didier, Mir, Olivier, Monreal, Manuel, Righini, Marc, Samama, Charles M, Syrigos, Kostas, Szmit, Sebastian, Torbicki, Adam, Verhamme, Peter, Vicaut, Eric, Wang, Tzu-Fei, Meyer, Guy, Laporte, Silvy

“…Cancer-associated thrombosis (CT) is associated with a high risk of recurrent venous thromboembolic (VTE) events that require extended anticoagulation in…”
Get more information

Anticoagulant treatment of cancer-associated thromboembolism by Mahé, Isabelle, Mayeur, Didier, Couturaud, Francis, Scotté, Florian, Benhamou, Ygal, Benmaziane, Asmahane, Bertoletti, Laurent, Laporte, Silvy, Girard, Philippe, Mismetti, Patrick, Sanchez, Olivier

“…Venous thromboembolism (VTE) is a frequent and potentially fatal complication in patients with cancer. During the initial period after the thromboembolic…”
Get full text

Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations by Mahé, Isabelle, Mayeur, Didier, Krakowski, Ivan

“…Purpose Venous thromboembolism (VTE) is one of the most frequent events associated with cancer, requiring hospitalization and generating additional healthcare…”
Get full text

Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy by Roussot, Nicolas, Constantin, Guillaume, Desmoulins, Isabelle, Bergeron, Anthony, Arnould, Laurent, Beltjens, Françoise, Mayeur, Didier, Kaderbhai, Courèche, Hennequin, Audrey, Jankowski, Clémentine, Padeano, Marie Martine, Costaz, Hélène, Jacinto, Sarah, Michel, Eloise, Amet, Alix, Coutant, Charles, Costa, Brigitte, Jouannaud, Christelle, Deblock, Mathilde, Levy, Christelle, Ferrero, Jean-Marc, Kerbrat, Pierre, Brain, Etienne, Mouret-Reynier, Marie-Ange, Coudert, Bruno, Bertaut, Aurélie, Ladoire, Sylvain

“…The CPS+EG scoring system was initially described in unselected early breast cancer (eBC) patients treated with neoadjuvant chemotherapy (NAC), leading to…”
Get full text

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey by Potere, Nicola, Mahé, Isabelle, Angchaisuksiri, Pantep, Cesarman-Maus, Gabriela, Tan, Chee Wee, Rashid, Anila, AlGahtani, Farjah H., Imbalzano, Egidio, van Es, Nick, Leader, Avi, Olayemi, Edeghonghon, Porreca, Ettore, Ní Áinle, Fionnuala, Okoye, Helen C., Candeloro, Matteo, Mayeur, Didier, Valerio, Luca, Clark, R. Cary, Castellucci, Lana A., Barco, Stefano, Di Nisio, Marcello

“…Venous thromboembolism (VTE) is a major preventable cause of morbidity, disability, and mortality in subjects with cancer. A global appraisal of…”
Get full text

Treatment of cancer-associated venous thromboembolism in patients under palliative care by Debourdeau, Philippe, Sevestre, Marie-Antoinette, Bertoletti, Laurent, Mayeur, Didier, Girard, Philippe, Scotté, Florian, Sanchez, Olivier, Mahé, Isabelle

“…Many patients with cancer require palliative care at some stage and the vast majority of people followed in palliative care are cancer patients. Patients with…”
Get full text